(CC) Chemours - Overview
Stock: Refrigerants, Pigments, Coatings, Films, Polymers
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.80% |
| Yield on Cost 5y | 2.23% |
| Yield CAGR 5y | -15.33% |
| Payout Consistency | 82.4% |
| Payout Ratio | 56.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 68.6% |
| Relative Tail Risk | -11.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.29 |
| Alpha | -26.86 |
| Character TTM | |
|---|---|
| Beta | 2.149 |
| Beta Downside | 1.844 |
| Drawdowns 3y | |
|---|---|
| Max DD | 73.60% |
| CAGR/Max DD | -0.22 |
Description: CC Chemours January 16, 2026
Chemours Co (NYSE:CC) is a diversified performance-chemicals producer operating worldwide across three business units: Thermal & Specialized Solutions (refrigerants, propellants, foam blowing agents under Freon/Opteon), Titanium Technologies (Ti-O₂ pigment sold as Ti-Pure), and Advanced Performance Materials (Teflon, Viton, Krytox, Nafion for electronics, semiconductors, transportation, energy, oil & gas, and medical markets). The firm distributes products both directly and through a network of resellers, agents, and distributors, and has been a standalone public company since its 2014 spin-off, headquartered in Wilmington, Delaware.
Key recent metrics: FY 2023 revenue was approximately **$5.5 billion**, with an adjusted operating margin of **~13 %**, reflecting strong pricing power in Ti-O₂ and specialty polymers. The Ti-O₂ segment contributes roughly **45 %** of total sales and is sensitive to global pigment price cycles, which have been supported by a **3-4 % CAGR** in construction-coating demand. The Thermal & Specialized Solutions unit faces regulatory headwinds from the global phase-down of high-global-warming-potential (H-GWP) refrigerants, prompting a shift toward low-GWP alternatives such as Opteon XL.
Sector drivers that materially affect Chemours include: (1) **Regulatory climate policy** accelerating adoption of low-GWP refrigerants and propellants, (2) **Growth in electric-vehicle thermal-management systems**, boosting demand for high-performance polymers, and (3) **Sustained construction activity** in emerging markets, underpinning Ti-O₂ consumption for paints and coatings.
For a deeper quantitative view of CC’s valuation metrics, you might explore the analyst tools on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -333.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA 8.89 > 1.0 |
| NWC/Revenue: 22.60% < 20% (prev 22.35%; Δ 0.25% < -1%) |
| CFO/TA 0.04 > 3% & CFO 265.0m > Net Income -333.0m |
| Net Debt (3.80b) to EBITDA (658.0m): 5.78 < 3 |
| Current Ratio: 1.71 > 1.5 & < 3 |
| Outstanding Shares: last quarter (150.2m) vs 12m ago 0.36% < -2% |
| Gross Margin: 17.40% > 18% (prev 0.19%; Δ 1721 % > 0.5%) |
| Asset Turnover: 78.12% > 50% (prev 78.11%; Δ 0.02% > 0%) |
| Interest Coverage Ratio: 1.25 > 6 (EBITDA TTM 658.0m / Interest Expense TTM 267.0m) |
Altman Z'' 2.16
| A: 0.18 (Total Current Assets 3.21b - Total Current Liabilities 1.88b) / Total Assets 7.57b |
| B: 0.17 (Retained Earnings 1.31b / Total Assets 7.57b) |
| C: 0.04 (EBIT TTM 333.0m / Avg Total Assets 7.52b) |
| D: 0.14 (Book Value of Equity 1.03b / Total Liabilities 7.27b) |
| Altman-Z'' Score: 2.16 = BBB |
Beneish M -2.99
| DSRI: 0.99 (Receivables 947.0m/951.0m, Revenue 5.87b/5.83b) |
| GMI: 1.12 (GM 17.40% / 19.44%) |
| AQI: 1.02 (AQ_t 0.13 / AQ_t-1 0.13) |
| SGI: 1.01 (Revenue 5.87b / 5.83b) |
| TATA: -0.08 (NI -333.0m - CFO 265.0m) / TA 7.57b) |
| Beneish M-Score: -2.99 (Cap -4..+1) = A |
What is the price of CC shares?
Over the past week, the price has changed by +22.21%, over one month by +37.95%, over three months by +57.17% and over the past year by +1.78%.
Is CC a buy, sell or hold?
- StrongBuy: 3
- Buy: 2
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 16.3 | -10.9% |
| Analysts Target Price | 16.3 | -10.9% |
| ValueRay Target Price | 19.3 | 5.3% |
CC Fundamental Data Overview February 05, 2026
P/S = 0.4242
P/B = 8.3094
P/EG = 1.6685
Revenue TTM = 5.87b USD
EBIT TTM = 333.0m USD
EBITDA TTM = 658.0m USD
Long Term Debt = 4.10b USD (from longTermDebt, last quarter)
Short Term Debt = 114.0m USD (from shortTermDebt, last quarter)
Debt = 4.42b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.80b USD (from netDebt column, last quarter)
Enterprise Value = 6.28b USD (2.48b + Debt 4.42b - CCE 613.0m)
Interest Coverage Ratio = 1.25 (Ebit TTM 333.0m / Interest Expense TTM 267.0m)
EV/FCF = -523.2x (Enterprise Value 6.28b / FCF TTM -12.0m)
FCF Yield = -0.19% (FCF TTM -12.0m / Enterprise Value 6.28b)
FCF Margin = -0.20% (FCF TTM -12.0m / Revenue TTM 5.87b)
Net Margin = -5.67% (Net Income TTM -333.0m / Revenue TTM 5.87b)
Gross Margin = 17.40% ((Revenue TTM 5.87b - Cost of Revenue TTM 4.85b) / Revenue TTM)
Gross Margin QoQ = 15.72% (prev 17.21%)
Tobins Q-Ratio = 0.83 (Enterprise Value 6.28b / Total Assets 7.57b)
Interest Expense / Debt = 1.54% (Interest Expense 68.0m / Debt 4.42b)
Taxrate = 32.28% (41.0m / 127.0m)
NOPAT = 225.5m (EBIT 333.0m * (1 - 32.28%))
Current Ratio = 1.71 (Total Current Assets 3.21b / Total Current Liabilities 1.88b)
Debt / Equity = 14.82 (Debt 4.42b / totalStockholderEquity, last quarter 298.0m)
Debt / EBITDA = 5.78 (Net Debt 3.80b / EBITDA 658.0m)
Debt / FCF = -316.8 (out of range, set to none) (Net Debt 3.80b / FCF TTM -12.0m)
Total Stockholder Equity = 429.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -4.43% (Net Income -333.0m / Total Assets 7.57b)
RoE = -77.53% (Net Income TTM -333.0m / Total Stockholder Equity 429.5m)
RoCE = 7.36% (EBIT 333.0m / Capital Employed (Equity 429.5m + L.T.Debt 4.10b))
RoIC = 4.95% (NOPAT 225.5m / Invested Capital 4.56b)
WACC = 5.64% (E(2.48b)/V(6.89b) * Re(13.84%) + D(4.42b)/V(6.89b) * Rd(1.54%) * (1-Tc(0.32)))
Discount Rate = 13.84% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.55%
Fair Price DCF = unknown (Cash Flow -12.0m)
EPS Correlation: -56.15 | EPS CAGR: -26.04% | SUE: -0.66 | # QB: 0
Revenue Correlation: -50.71 | Revenue CAGR: -1.38% | SUE: -0.08 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.14 | Chg30d=-0.023 | Revisions Net=-2 | Analysts=5
EPS next Year (2026-12-31): EPS=1.73 | Chg30d=-0.028 | Revisions Net=-3 | Growth EPS=+79.2% | Growth Revenue=+4.0%